|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-16.80/-1.80
|
企业价值
9.53M
|
资产负债 |
每股账面净值
1.18
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.61M
|
每股收益
2.22
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/05 03:25 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products. |